RBC Europe’s Elevance Health ELV Stock Holding History

RBC Europe’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$14K	Hold	30	–	–	﹤0.01%	461
2022 Q1	$15K	Hold	30	–	–	﹤0.01%	487
2021 Q4	$14K	Hold	30	–	–	﹤0.01%	496
2021 Q3	$11.2K	Sell	30 -155	-84%	-$58.9K	﹤0.01%	914
2021 Q2	$70.6K	Hold	185	–	–	﹤0.01%	521
2021 Q1	$66.4K	Hold	185	–	–	﹤0.01%	492
2020 Q4	$59.4K	Hold	185	–	–	﹤0.01%	478
2020 Q3	$49.7K	Hold	185	–	–	﹤0.01%	460
2020 Q2	$48.7K	Hold	185	–	–	﹤0.01%	449
2020 Q1	$42K	Hold	185	–	–	﹤0.01%	422
2019 Q4	$55.9K	Buy	185 +30	+19%	+$8.26K	﹤0.01%	426
2019 Q3	$37.2K	Sell	155 -155	-50%	-$42.5K	﹤0.01%	499
2019 Q2	$87.5K	Hold	310	–	–	0.01%	362
2019 Q1	$89K	Hold	310	–	–	0.01%	349
2018 Q4	$81.4K	Sell	310 -150	-33%	-$41.2K	0.01%	346
2018 Q3	$126K	Hold	460	–	–	0.01%	316
2018 Q2	$109K	Hold	460	–	–	0.01%	340
2018 Q1	$101K	Hold	460	–	–	0.01%	340
2017 Q4	$104K	Hold	460	–	–	0.01%	342
2017 Q3	$87.3K	Buy	+460	New	+$87.5K	0.01%	383

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

RBC Europe's ELV Position: Q2 2022 in Review

RBC Europe held its Elevance Health (ELV) position steady in Q2 2022 at 30 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

RBC Europe first reported a position in ELV in Q3 2017 and has held it in 20 quarters since. The position peaked at $126K in Q3 2018. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

RBC Europe held 30 shares of Elevance Health worth $14K as of Q2 2022.
RBC Europe left its Elevance Health share count unchanged in Q2 2022.
Elevance Health made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #461 holding.
RBC Europe first reported a position in Elevance Health in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Elevance Health position peaked at $126K in Q3 2018.
1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.